Key result
The ACS:180 cardiac troponin I assay was equally efficient to CK-MB and cTnT for diagnosing acute myocardial infarction and identifying high-risk unstable angina.
Why the study?
Does the ACS:180 cardiac troponin I assay perform as well as other cardiac biomarkers in diagnosing acute myocardial infarction and identifying high-risk unstable angina?
Observational
Does the ACS:180 cardiac troponin I assay perform as well as other cardiac biomarkers in diagnosing acute myocardial infarction and identifying high-risk unstable angina?
The ACS:180 cardiac troponin I assay is as efficient as CK-MB and cTnT for diagnosing acute myocardial infarction and risk-stratifying unstable angina.
Answers are grounded in this paper and cite their sources.
Supports troponin I assay use in suspected ACS; leaves open need for validation against modern high-sensitivity assays.
All patients admitted to the coronary care unit with suspected acute coronary syndromes were evaluated by serial electrocardiography and blood draws on admission and at 4 and 12h from admission. Diagnosis was based on conventional WHO criteria. Samples were measured for creatine kinase (CK), cardiac troponin T (cTnT), myoglobin, CK isoenzyme MB (CK-MB) and cardiac troponin I (cTnI). A set of samples from individuals undergoing extreme endurance training was also examined. Analytical imprecision was consistent with published quality goals. Samples were stable for cTnI under a range of storage conditions, including multiple freeze-thaw cycles. CK-MB, cTnI and cTnT were equally efficient for the diagnosis of acute myocardial infarction, irrespective of the final diagnostic criteria used. Both cTnI and cTnT were of equal efficiency in the identification of a high-risk subgroup of patients with unstable angina. Significant elevations of cTnI were not seen in an endurance-training group.
No takes yet. Share an insight, caveat, or question.
Collinson et al. (2001) conducted an observational in Suspected acute coronary syndromes. ACS:180 cardiac troponin I assay vs. CK-MB and cTnT assays was evaluated on Diagnosis of acute myocardial infarction. The ACS:180 cardiac troponin I assay was equally efficient to CK-MB and cTnT for diagnosing acute myocardial infarction and identifying high-risk unstable angina.
Synapse has enriched 10 related papers. Consider them for comparative context: